Literature DB >> 6459289

Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.

G M Bahr, G A Rook, J L Stanford.   

Abstract

Soluble antigen preparations from Mycobacterium leprae are reported to inhibit the response to other stimuli, of peripheral blood mononuclear cells from lepromatous leprosy cases (BL/LL) and also from tuberculoid cases (TT/BL) and normal donors. We confirm these findings and in addition, report that a similar suppressive effect is exerted by antigen from Mycobacterium vaccae, Mycobacterium nonchromogenicum and, to a lesser extent, Mycobacterium tuberculosis and Mycobactyerium kansasii. Moreover, suppression is seen using peripheral blood mononuclear cells from individuals unlikely to have encountered the organism used. The suppression is not due to toxicity of the antigen preparation, and is not indomethacin sensitive. It involves a cell found in the E-rosetting population, which loses its ability to suppress or be suppressed, after 48 hr in culture. Possible explanations include a pharmacological effect of cell wall peptidoglycolipids, or the triggering of suppressor cells specific for common mycobacterial antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459289      PMCID: PMC1554959     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  Lepromin-induced suppressor cells in patients with leprosy.

Authors:  V Mehra; L H Mason; J P Fields; B R Bloom
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  A preliminary study of the effect of contact with environmental mycobacteria on the pattern of sensitivity to a range of new tuberculins amongst Ugandan adults.

Authors:  J L Stanford; R C Paul
Journal:  J Hyg (Lond)       Date:  1976-04

3.  Multiple skin testing of Kenyan schoolchildren with a series of new tuberculins.

Authors:  R C Paul; J L Stanford; O Misljenóvic; J Lefering
Journal:  J Hyg (Lond)       Date:  1975-10

4.  In vitro lymphocyte stimulation in leprosy; simultaneous stimulation with Mycobacterium leprae antigens and phytohaemagglutinin.

Authors:  G Bjune
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.

Authors:  I Nath; R Singh
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.

Authors:  T Godal; B Myklestad; D R Samuel; B Myrvang
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

7.  Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients.

Authors:  V Mehra; L H Mason; W Rothman; E Reinherz; S F Schlossman; B R Bloom
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

8.  Production of a suppressor factor by human adherent cells treated with mycobacteria.

Authors:  A A Wadee; R Sher; A R Rabson
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  5 in total

1.  Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors.

Authors:  G A Rook; J Steele; S Barnass; J Mace; J L Stanford
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen.

Authors:  C S Chujor; B Kuhn; B Schwerer; H Bernheimer; W R Levis; D Bevec
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

3.  Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever.

Authors:  G M Bahr; A M Yousof; K Behbehani; H A Majeed; S Sakkalah; K Souan; I Jarrad; C Geoffroy; J E Alouf
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

4.  Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.

Authors:  G M Bahr; F Z Modabber; A Morin; M Terrier; A Eyquem; L Chedid
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy.

Authors:  W E Bullock; S Watson; K E Nelson; V Schauf; S Makonkawkeyoon; R R Jacobson
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.